Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Life expectancy of HIV-positive Canadians rises to 65 years: study

The study, from the Canadian Observational Cohort Collaboration, indicated the overall life expectancy of Canadians undergoing antiretroviral treatment for the AIDS-causing virus had climbed to 65 years -- about a 16-year jump since 2000.

Published
10 August 2015
From
CTV News
HIV grows despite treatment, study finds

A study by the University’s Institute of Infection and Global Health measured the levels of integrated HIV in the CD4 cells of patients undergoing uninterrupted treatment for up to 14 years, comparing patients receiving treatment for different lengths of time. The researchers discovered that the amount of HIV found to be integrated in the CD4 cells was undiminished from year 1 to year 14.

Published
07 August 2015
From
University of Liverpool press release
Starting ART reduces TB risk for HIV-positive patients in South Africa

Starting antiretroviral therapy (ART) significantly reduces the risk of tuberculosis (TB) for patients in South Africa, investigators report in the online edition of AIDS. Overall, ART initiation was associated

Published
07 August 2015
By
Michael Carter
WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV

A study of antiretroviral treatment specifically for women with HIV showed that a single-tablet regimen containing the integrase inhibitor elvitegravir suppressed the virus better than a regimen

Published
06 August 2015
By
Liz Highleyman
Four years with HIV and counting…

Today marks my fourth anniversary, or annHIVersary if you will, of life with HIV. Those four years have really flown past, so what’s changed? What does the future hold?

Published
04 August 2015
From
Beyond Positive
Waking up HIV: Two compounds show great potential to rouse latent virus

Researchers at UC Davis have identified a compound that activates latent HIV, offering the tantalizing possibility that the virus can be flushed out of the silent reservoirs and fully cured. Even better, the compound (PEP005) is already approved by the FDA. The study was published in the journal PLoS Pathogens.

Published
04 August 2015
From
UC Davis press release
Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.

Published
04 August 2015
From
Intellectual Property Watch
GSK flags up pipeline as HIV drugs help it beat profit forecasts

GlaxoSmithKline moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped it beat quarterly profit forecasts.

Published
30 July 2015
From
Reuters
Intensification of antiretroviral therapy reduces risk of late-term mother-to-child HIV transmission

Maternal and infant antiretroviral therapy (ART) intensification is very effective in preventing HIV transmission during labour and birth in pregnant women with HIV in Thailand who present late

Published
29 July 2015
By
Carole Leach-Lemens
Implant and injectable hormonal contraception most effective methods for women living with HIV

Hormonal contraceptive methods are highly effective in reducing the risk of pregnancy in women living with HIV whether on antiretroviral therapy (ART) or not, according to an evaluation

Published
29 July 2015
By
Carole Leach-Lemens

Filter by country